Neurotech Takes The Stage At JPM 2024 : vimarsana.com

Neurotechnology, cognitive biomarkers, Alzheimer's drugs, diagnostics, AI, VR, and more were topics of investor discussion at the 2024 JP Morgan Healthcare Conference.

Related Keywords

Boston , Massachusetts , United States , Michael Notaras , Walter Greenleaf , Neo Auvra , Tarcan Kiper , Beth Rogozinski , Alex Morgan , Beth Hoffman , Shirley Bergin , Jim Anthony , Jenny Rooke , Ekaterine Kortkhonjia , Andrei Georgescu , Sarah Hill , Brent Vaughan , Eli Lilly , Tom Oxley , Christian Howell , David Maltz , David Suendermann Oeft , Marc Jones , Hanna Wexler , Marc Edwards , Abraham Heifets , Jp Morgan , Gates Foundation , Alzheimer Drug Discovery Foundation , Boston Scientific , Startup Health , Butterfly Network , Cognito Therapeutics , Genoa Ventures , Jnj Innovation , Nalu Medical , Central Nervous System , Drug Discovery , Decheng Capital , Origami Therapeutics , Khosla Ventures , Apple Watch Parkinson , Neuroscience Innovation , Fda , Neurotech , Neurotechnology , Digital Biomarkers , Clinical Trials , Pharma , Life Sciences , Brain Computer Interface ,